End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.45 TWD | -2.84% | +7.99% | +8.35% |
2023 | BRIM Biotechnology, Inc.(TPEX:6885) added to S&P Global BMI Index | CI |
2022 | BRIM Biotechnology, Inc. announced that it has received $20 million in funding | CI |
Sales 2022 | 0.53 17.14 43.86 | Sales 2023 | 0.09 2.93 7.5 | Capitalization | 3.47B 113B 289B |
---|---|---|---|---|---|
Net income 2022 | -274M -8.93B -22.85B | Net income 2023 | -688M -22.41B -57.36B | EV / Sales 2022 | 5,18,26,80,798 x |
Net cash position 2022 | 832M 27.09B 69.33B | Net cash position 2023 | 1.69B 55.12B 141B | EV / Sales 2023 | 19,71,99,58,889 x |
P/E ratio 2022 |
-9.92
x | P/E ratio 2023 |
-4.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | -2.84% | ||
1 week | +7.99% | ||
Current month | -1.07% | ||
1 month | -3.99% | ||
3 months | +13.26% | ||
6 months | -54.99% | ||
Current year | +8.35% |
Managers | Title | Age | Since |
---|---|---|---|
Hai Shan Jian
CEO | Chief Executive Officer | - | 31/13/31 |
Wen Chi Lee
FOU | Founder | - | 31/13/31 |
Fu Pin Wu
DFI | Director of Finance/CFO | - | 21/22/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ta Kun Shih
BRD | Director/Board Member | 72 | 15/22/15 |
Hsiu Lien Lin
BRD | Director/Board Member | - | 15/22/15 |
Hai Shan Jian
CEO | Chief Executive Officer | - | 31/13/31 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 32.45 | -2.84% | 625,477 |
25/24/25 | 33.4 | +5.20% | 1,991,485 |
24/24/24 | 31.75 | +5.83% | 1,102,405 |
23/24/23 | 30 | +1.01% | 138,072 |
22/24/22 | 29.7 | -1.16% | 437,823 |
End-of-day quote Taipei Exchange, April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+8.35% | 115M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 6885 Stock